‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

A request by CRISPR scientists to withdraw their patents over allegations of mishandling by the EPO’s Boards of Appeals has thrust a ‘fundamentally unfair, uncertain system’ into sharp focus, finds Sarah Speight.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com

More on this story

New York Times reframes OpenAI suit, sharpens focus on Microsoft

WIPO: We’re reaching a ‘critical mass’ on searchable, verified SEP data

Winston Taylor adds former ITC attorney with complex litigation nous

Tata customers Apple and Tesla reportedly held to ransom after hack

UK court sets Warner and Paramount interim licence rate payable to Nokia

Coach drops Quince dupe lawsuit after Ugg verdict

SpaceX launches into public orbit, but what now for its secretive IP strategy?

Cahill drafts in ex-King & Spalding tech litigation partner

‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

More on this story

Editor's picks

Editor's picks

More articles